{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:32:35Z","timestamp":1782772355505,"version":"3.54.5"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032230","name":"Radiation Research Foundation","doi-asserted-by":"publisher","award":["5.2.1.1"],"award-info":[{"award-number":["5.2.1.1"]}],"id":[{"id":"10.13039\/100032230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032230","name":"Radiation Research Foundation","doi-asserted-by":"publisher","award":["0\/2\/24\/I\/CFLA\/001"],"award-info":[{"award-number":["0\/2\/24\/I\/CFLA\/001"]}],"id":[{"id":"10.13039\/100032230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032230","name":"Radiation Research Foundation","doi-asserted-by":"publisher","award":["53\/OSI\/PA"],"award-info":[{"award-number":["53\/OSI\/PA"]}],"id":[{"id":"10.13039\/100032230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","award":["57702280"],"award-info":[{"award-number":["57702280"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","award":["CA23156"],"award-info":[{"award-number":["CA23156"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005067","name":"Franco-Bavarian Centre for University Cooperation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["DFG DE1546\/12-1"],"award-info":[{"award-number":["DFG DE1546\/12-1"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["FK03-2020"],"award-info":[{"award-number":["FK03-2020"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-CE92-0080"],"award-info":[{"award-number":["ANR-22-CE92-0080"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2025.118486","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T16:06:22Z","timestamp":1765641982000},"page":"118486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Targeting neuroinflammation by activation of the sigma-1 receptor (S1R) and inhibition of butyrylcholinesterase (hBChE) leads to highly potent anti-amnesic compounds in an Alzheimer's disease mouse model"],"prefix":"10.1016","volume":"305","author":[{"given":"Kora","family":"Reichau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Crouzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Gehrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Flake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Bertrand-Gaday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Chatonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liga","family":"Zvejniece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Sotriffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4074-6793","authenticated-orcid":false,"given":"Tangui","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6773-6245","authenticated-orcid":false,"given":"Michael","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118486_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An english translation of alzheimer\u2019s 1907 paper, \u201c\u00fcber eine eigenartige erkankung der hirnrinde","volume":"8","author":"Stelzmann","year":"1995","journal-title":"Clin. Anat."},{"key":"10.1016\/j.ejmech.2025.118486_bib2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1017\/S135561771700100X","article-title":"Alzheimer\u2019s Disease: Past, Present, and Future","volume":"23","author":"Bondi","year":"2017","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.ejmech.2025.118486_bib3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejmech.2025.118486_bib4","doi-asserted-by":"crossref","first-page":"120715","DOI":"10.1016\/j.jns.2023.120715","article-title":"New cases of dementia are rising in elderly populations in Wales, UK","volume":"451","author":"Stevenson-Hoare","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejmech.2025.118486_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2024.1399121","article-title":"Alzheimer\u2019s disease and its treatment\u2013yesterday, today, and tomorrow","volume":"15","author":"Kim","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118486_bib6","unstructured":"Cathy Greenblat, Dementia, 2025. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia#:\u223c:text=In%202021%2C%2057%20million%20people,for%20people%20living%20with%20dementia. (accessed 11 September 2025)."},{"key":"10.1016\/j.ejmech.2025.118486_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejmech.2025.118486_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2023.1081938","article-title":"Amyloid-beta aggregation implicates multiple pathways in Alzheimer\u2019s disease: Understanding the mechanisms","volume":"17","author":"Iliyasu","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118486_bib9","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejmech.2025.118486_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimer\u2019s Dement.: Transl. Res. Clin. Interv."},{"key":"10.1016\/j.ejmech.2025.118486_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.796867","article-title":"The Impact of Systemic Inflammation on Alzheimer\u2019s Disease Pathology","volume":"12","author":"Xie","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118486_bib12","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1021\/acschemneuro.9b00333","article-title":"Understanding the Role of Systemic Inflammation in Alzheimer\u2019s Disease","volume":"10","author":"Walker","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118486_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejmech.2025.118486_bib14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tips.2024.05.005","article-title":"Multi-target drugs for Alzheimer\u2019s disease","volume":"45","author":"Turgutalp","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.118486_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2020.04.008","article-title":"A Perspective on Multi-target Drugs for Alzheimer\u2019s Disease","volume":"41","author":"Benek","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.118486_bib16","doi-asserted-by":"crossref","first-page":"107152","DOI":"10.1016\/j.bioorg.2024.107152","article-title":"A comprehensive review of multi-target directed ligands in the treatment of Alzheimer\u2019s disease","volume":"144","author":"Pathak","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib17","doi-asserted-by":"crossref","first-page":"116569","DOI":"10.1016\/j.ejmech.2024.116569","article-title":"New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands","volume":"275","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/1567205013666160404120542","article-title":"Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer\u2019s Disease","volume":"13","author":"Sultan Darvesh","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2025.118486_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar \u03b2-amyloid in an Alzheimer mouse model","volume":"298","author":"Reid","year":"2015","journal-title":"Neurosci"},{"key":"10.1016\/j.ejmech.2025.118486_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1126\/science.98.2539.201.b","article-title":"On the Type of Cholinesterase Present in Brain Tissue","volume":"98","author":"Mendel","year":"1943","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118486_bib21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmech.2017.03.062","article-title":"Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer\u2019s disease","volume":"132","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3565(24)39312-7","article-title":"Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase","volume":"293","author":"Xie","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2025.118486_bib23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine","volume":"110","author":"Mesulam","year":"2002","journal-title":"Neurosci"},{"key":"10.1016\/j.ejmech.2025.118486_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2022.876019","article-title":"Phenotypic Displays of Cholinergic Enzymes Associate With Markers of Inflammation, Neurofibrillary Tangles, and Neurodegeneration in Pre- and Early Symptomatic Dementia Subjects","volume":"14","author":"Teitsdottir","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2025.118486_bib25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/13543776.2022.2083956","article-title":"Butyrylcholinesterase inhibitors as potential anti-Alzheimer\u2019s agents: an updated patent review (2018-present), Expert Opin","volume":"32","author":"Fern\u00e1ndez-Bola\u00f1os","year":"2022","journal-title":"Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.118486_bib26","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer\u2019s Disease Mouse Model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1039\/D2MD00087C","article-title":"Novel benzimidazole-based pseudo-irreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer\u2019s disease mouse model","volume":"13","author":"Spatz","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14814","article-title":"The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer\u2019s disease","volume":"30","author":"Carles","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2025.118486_bib29","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1021\/acs.jmedchem.1c00534","article-title":"Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer\u2019s Disease Mouse Model","volume":"64","author":"Scheiner","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib30","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1021\/acs.jmedchem.1c00167","article-title":"Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib31","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/molecules27031060","article-title":"Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer\u2019s Activity Profile","volume":"27","author":"Makhaeva","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118486_bib32","doi-asserted-by":"crossref","first-page":"112766","DOI":"10.1016\/j.ejmech.2020.112766","article-title":"Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors","volume":"208","author":"Meden","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib33","doi-asserted-by":"crossref","first-page":"114248","DOI":"10.1016\/j.ejmech.2022.114248","article-title":"From tryptophan-based amides to tertiary amines: Optimization of a butyrylcholinesterase inhibitor series","volume":"234","author":"Meden","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/164_2017_15","article-title":"Sigma-1 (\u03c31) Receptor in Memory and Neurodegenerative Diseases, Sigma Proteins: Evolution of the Concept of Sigma Receptors","volume":"244","author":"Maurice","year":"2017","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.ejmech.2025.118486_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/17460441.2021.1838483","article-title":"Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders","volume":"16","author":"Maurice","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118486_bib36","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118486_bib37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","article-title":"The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems","volume":"37","author":"Su","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.118486_bib38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3565(24)39299-7","article-title":"Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration","volume":"293","author":"Hayashi","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2025.118486_bib39","first-page":"1","article-title":"Sigma-1 Receptor: A Potential Therapeutic Target for Traumatic Brain Injury","author":"Shi","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118486_bib40","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bbamem.2016.03.018","article-title":"On the physiological\/pathological link between A\u03b2 peptide, cholesterol, calcium ions and membrane deformation: A molecular dynamics study","volume":"1858","author":"Pannuzzo","year":"2016","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.ejmech.2025.118486_bib41","first-page":"1","article-title":"Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases","author":"Ryskamp","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118486_bib42","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1073\/pnas.1422001112","article-title":"Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid","volume":"112","author":"Tsai","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118486_bib43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2012.01.030","article-title":"The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements","volume":"682","author":"Pal","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118486_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-017-9838-2","article-title":"Sigma-1 Receptor Agonists Induce Oxidative Stress in Mitochondria and Enhance Complex I Activity in Physiological Condition but Protect Against Pathological Oxidative Stress","volume":"35","author":"Goguadze","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejmech.2025.118486_bib45","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s11064-023-03960-6","article-title":"Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson\u2019s Disease","volume":"48","author":"Siddiqui","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2025.118486_bib46","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00001756-200508010-00018","article-title":"Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity","volume":"16","author":"Marrazzo","year":"2005","journal-title":"NeuroReport"},{"key":"10.1016\/j.ejmech.2025.118486_bib47","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor","volume":"149","author":"Meunier","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118486_bib48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-4522(97)00405-3","article-title":"Sigma1 (\u03c31) receptor agonists and neurosteroids attenuate \u03b225\u201335-amyloid peptide-induced amnesia in mice through a common mechanism","volume":"83","author":"Maurice","year":"1998","journal-title":"Neurosci"},{"key":"10.1016\/j.ejmech.2025.118486_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12149-007-0094-z","article-title":"Low density of sigma1 receptors in early Alzheimer\u2019s disease","volume":"22","author":"Mishina","year":"2008","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.118486_bib50","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0269881110379286","article-title":"Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor\/sigma1 (\u03c31) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative","volume":"25","author":"Villard","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejmech.2025.118486_bib51","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1021\/acs.jmedchem.0c02265","article-title":"Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective","volume":"64","author":"Fallica","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib52","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-3565(25)20283-X","article-title":"Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand","volume":"259","author":"Su","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2025.118486_bib53","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1021\/acs.jmedchem.3c00541","article-title":"Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist\/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer\u2019s Disease Mouse Model","volume":"66","author":"Spatz","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib54","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/jm00034a020","article-title":"Structural features important for sigma 1 receptor binding","volume":"37","author":"Glennon","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib55","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature17391","article-title":"Crystal structure of the human \u03c31 receptor","volume":"532","author":"Schmidt","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118486_bib56","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejmech.2018.02.024","article-title":"Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties","volume":"151","author":"Linkens","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib57","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1021\/ml3001825","article-title":"Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer","volume":"3","author":"Darras","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118486_bib58","doi-asserted-by":"crossref","first-page":"105844","DOI":"10.1016\/j.bioorg.2022.105844","article-title":"Carbamate-based N-Substituted tryptamine derivatives as novel pleiotropic molecules for Alzheimer\u2019s disease","volume":"125","author":"Zhang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2014.05.002","article-title":"Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine","volume":"81","author":"Huang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib63","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/acs.jmedchem.5b01674","article-title":"Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode","volume":"59","author":"Sawatzky","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib64","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cbi.2010.02.013","article-title":"Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates","volume":"187","author":"Camps","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.118486_bib65","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.bmcl.2013.02.017","article-title":"Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer\u2019s disease","volume":"23","author":"Romero","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118486_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurements with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib61","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/syn.20230","article-title":"Differences in the allosteric modulation by phenytoin of the binding properties of the \u03c31 ligands [3H](+)-pentazocine and [3H]NE-100","volume":"59","author":"Cobos","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.ejmech.2025.118486_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0922-4106(94)90115-5","article-title":"Rat liver and kidney contain high densities of \u03c31 and \u03c32 receptors: characterization by ligand binding and photoaffinity labeling","volume":"268","author":"Hellewell","year":"1994","journal-title":"Eur. J. Pharmacol. Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118486_bib66","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bph.12506","article-title":"The cognition-enhancing activity of E1R, a novel positive allosteric modulator of sigma-1 receptors","volume":"171","author":"Zvejniece","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118486_bib67","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ptr.8068","article-title":"Convolamine, a tropane alkaloid extracted from Convolvulus plauricalis, is a potent sigma-1 receptor-positive modulator with cognitive and neuroprotective properties","volume":"38","author":"Crouzier","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejmech.2025.118486_bib68","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1016\/j.apsb.2024.06.013","article-title":"Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the \u03c31 chaperone protein","volume":"14","author":"Garc\u00eda-Pupo","year":"2024","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.ejmech.2025.118486_bib69","doi-asserted-by":"crossref","first-page":"100016","DOI":"10.1016\/j.tjpad.2024.100016","article-title":"Blarcamesine for the treatment of Early Alzheimer\u2019s Disease: Results from the ANAVEX2-73-AD-004 Phase IIB\/III trial","volume":"12","author":"Macfarlane","year":"2025","journal-title":"J. Prev. Alzheimers. Dis."},{"key":"10.1016\/j.ejmech.2025.118486_bib70","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0021-9258(19)75920-1","article-title":"p-Nitrophenyl and cholesteryl-N-alkyl carbamates as inhibitors of cholesterol esterase","volume":"262","author":"Hosie","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib71","doi-asserted-by":"crossref","first-page":"16723","DOI":"10.1021\/bi961677v","article-title":"Molecular Recognition by Cholesterol Esterase of Active Site Ligands: Structure\u2212Reactivity Effects for Inhibition by Aryl Carbamates and Subsequent Carbamylenzyme Turnover","volume":"35","author":"Feaster","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118486_bib72","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1021\/jacs.1c13492","article-title":"Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition in Vitro and Enable Restoration of Cognition in an Alzheimer\u2019s Disease Mouse Model upon Irradiation","volume":"144","author":"Scheiner","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118486_bib73","series-title":"Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists","first-page":"1","author":"Copeland","year":"2013"},{"key":"10.1016\/j.ejmech.2025.118486_bib74","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/cmdc.201600223","article-title":"A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety","volume":"11","author":"Sawatzky","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118486_bib75","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib76","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/ci500118s","article-title":"Docking covalent inhibitors: a parameter free approach to pose prediction and scoring","volume":"54","author":"Zhu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118486_bib77","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1021\/jp104258d","article-title":"Catalytic Reaction Mechanism of Acetylcholinesterase Determined by Born\u2212Oppenheimer Ab Initio QM\/MM Molecular Dynamics Simulations","volume":"114","author":"Zhou","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2025.118486_bib78","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1432-1033.1996.00036.x","article-title":"Asp70 in the Peripheral Anionic Site of Human Butyrylcholinesterase","volume":"235","author":"Masson","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2025.118486_bib79","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.bmcl.2015.01.067","article-title":"Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists","volume":"25","author":"Austin","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118486_bib80","doi-asserted-by":"crossref","first-page":"109733","DOI":"10.1016\/j.neuropharm.2023.109733","article-title":"Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer\u2019s disease","volume":"242","author":"Freyssin","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.118486_bib81","doi-asserted-by":"crossref","first-page":"108526","DOI":"10.1016\/j.yebeh.2021.108526","article-title":"Fenfluramine modulates the anti-amnesic effects induced by sigma-1 receptor agonists and neuro(active)steroids in vivo","volume":"127","author":"Martin","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ejmech.2025.118486_bib82","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbr.2015.09.020","article-title":"Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments","volume":"296","author":"Maurice","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2025.118486_bib83","first-page":"241","article-title":"Comparison of methods for evaluating drug-drug interaction","volume":"2","author":"Zhao","year":"2010","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejmech.2025.118486_bib84","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.118486_bib85","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib86","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/ml400304w","article-title":"Structures of Human Acetylcholinesterase Bound to Dihydrotanshinone I and Territrem B Show Peripheral Site Flexibility","volume":"4","author":"Cheung","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118486_bib87","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1039\/C9CC01330J","article-title":"Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer\u2019s disease","volume":"55","author":"Meden","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.118486_bib88","unstructured":"Schr\u00f6dinger\u2019s covalent reactions repository: https:\/\/learn.schrodinger.com\/private\/edu\/release\/current\/Documentation\/html\/covalent_docking\/covalent_docking_user_manual\/covdock_reactions_repository.htm (accessed 18 August 2025)."},{"key":"10.1016\/j.ejmech.2025.118486_bib89","first-page":"1752","volume":"26","author":"Banks","year":"2005","journal-title":"Integrated Modeling Program, Applied Chemical Theory (IMPACT), J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.118486_bib90","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(95)01032-7","article-title":"Amnesia induced in mice by centrally administered \u03b2-amyloid peptides involves cholinergic dysfunction","volume":"706","author":"Maurice","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.ejmech.2025.118486_bib91","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/npp.2013.70","article-title":"Blockade of Tau Hyperphosphorylation and A\u03b21\u201342 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and \u03c31 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer\u2019s Disease","volume":"38","author":"Lahmy","year":"2013","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.ejmech.2025.118486_bib92","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.107.133330","article-title":"The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase Deficiency","volume":"324","author":"Li","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:09:23Z","timestamp":1777529363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425012516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":92,"alternative-id":["S0223523425012516"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118486","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting neuroinflammation by activation of the sigma-1 receptor (S1R) and inhibition of butyrylcholinesterase (hBChE) leads to highly potent anti-amnesic compounds in an Alzheimer's disease mouse model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118486"}}